Credit Suisse Upgrades Pfizer (PFE) to Outperform

January 31, 2019 4:54 AM
Credit Suisse analyst Vamil Divan upgraded Pfizer (NYSE: PFE) from Neutral to Outperform with a price target ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Upgrades Upgrades

Next Articles